• 1. An analyte-triggered artificial peroxidase system based on dimanganese complex for a versatile enzyme assay?
  Suji Lee,Min Su Han Chem. Commun., 2021,57, 9450-9453
• 2. An atom-economical protocol for direct conversion of Baylis–Hillman alcohols to β-chloro aldehydes in water?
  Raktani Bikshapathi,Sai Prathima Parvathaneni,Vaidya Jayathirtha Rao Green Chem., 2017,19, 4446-4450
• 3. An artificial photosynthesis system comprising a covalent triazine framework as an electron relay facilitator for photochemical carbon dioxide reduction?
  Siquan Zhang,Shengyao Wang,Liping Guo,Hao Chen,Bien Tan,Shangbin Jin J. Mater. Chem. C, 2020,8, 192-200
• 4. An intermolecular C–C coupling reaction of iridium complexes?
  Kathrin Kutlescha,Rhett Kempe New J. Chem., 2010,34, 1954-1960
• 5. An alumina stabilized graphene oxide wrapped SnO2 hollow sphere LIB anode with improved lithium storage?
  Xiang Liu,Qian Sun,A. B. Djuri?i?,Maohai Xie,Baohu Dai,Jinyao Tang,Charles Surya,Changzhong Liao,Kaimin Shih RSC Adv., 2015,5, 100783-100789

Introduction to 4,6-Dibromo-3-chloro-2-methylphenol (CAS No. 2167148-36-7)

4,6-Dibromo-3-chloro-2-methylphenol, identified by the Chemical Abstracts Service Number (CAS No.) 2167148-36-7, is a specialized organic compound that has garnered significant attention in the field of pharmaceutical and agrochemical research. This compound, characterized by its bromine and chlorine substituents on a phenolic ring with a methyl group at the 2-position, exhibits unique chemical properties that make it a valuable intermediate in synthetic chemistry. Its molecular structure, featuring a halogenated aromatic system, positions it as a candidate for further functionalization in drug discovery and material science applications.

The chemical structure of 4,6-Dibromo-3-chloro-2-methylphenol consists of a benzene ring substituted with bromine atoms at the 4 and 6 positions, a chlorine atom at the 3 position, and a methyl group at the 2 position. This arrangement imparts distinct reactivity patterns, making it useful in cross-coupling reactions, nucleophilic substitutions, and other organic transformations. The presence of multiple halogen atoms enhances its utility as a building block in constructing more complex molecules, particularly in medicinal chemistry.

In recent years, there has been growing interest in halogenated phenols due to their role as key intermediates in the synthesis of bioactive compounds. 4,6-Dibromo-3-chloro-2-methylphenol is no exception and has been explored in several research studies for its potential applications. One notable area of investigation is its use as a precursor in the development of novel antimicrobial agents. The halogenated aromatic core is known to contribute to the bioactivity of small molecules by influencing their interactions with biological targets.

Recent advancements in computational chemistry have enabled researchers to predict the reactivity and biological activity of compounds like 4,6-Dibromo-3-chloro-2-methylphenol with higher accuracy. Molecular modeling studies have suggested that this compound may exhibit inhibitory effects on certain enzymes and receptors, making it a promising candidate for further pharmacological exploration. For instance, its structural motif is reminiscent of known antimicrobial agents that target bacterial cell wall synthesis or DNA gyrase inhibition.

The synthesis of 4,6-Dibromo-3-chloro-2-methylphenol typically involves multi-step organic reactions starting from commercially available aromatic precursors. The introduction of bromine and chlorine atoms can be achieved through electrophilic aromatic substitution reactions, often employing reagents such as N-bromosuccinimide (NBS) and sulfuryl chloride (SO?Cl?). The methyl group can be incorporated via Friedel-Crafts alkylation using dimethyl sulfate or methyl iodide in the presence of a Lewis acid catalyst.

One of the key challenges in working with 4,6-Dibromo-3-chloro-2-methylphenol is its potential sensitivity to hydrolysis under basic or acidic conditions. This necessitates careful handling and storage conditions to maintain its stability. However, its robustness under standard laboratory conditions makes it suitable for various synthetic protocols. Researchers have also explored its use in flow chemistry systems, where controlled reaction conditions enhance yield and purity.

The pharmaceutical industry has shown particular interest in halogenated phenols due to their versatility in drug design. 4,6-Dibromo-3-chloro-2-methylphenol serves as a versatile scaffold for generating structurally diverse derivatives through further functionalization. For example, reduction of the bromine or chlorine atoms can yield mono-halogenated phenols, which can then be subjected to diazotization followed by coupling reactions to introduce azo groups or other functional moieties.

In agrochemical research, 4,6-Dibromo-3-chloro-2-methylphenol has been investigated for its potential as an intermediate in the synthesis of herbicides and fungicides. The halogenated aromatic system contributes to the bioactivity of these compounds by enhancing their binding affinity to target enzymes or receptors in plants. Additionally, its structural features may confer resistance to degradation under environmental conditions, improving the efficacy of agrochemical formulations.

The environmental impact of using compounds like 4,6-Dibromo-3-chloro-2-methylphenol is also a consideration in modern research. Efforts are being made to develop greener synthetic routes that minimize waste and hazardous byproducts. Catalytic methods and solvent-free reactions are being explored as alternatives to traditional approaches. Furthermore, biodegradability studies are being conducted to assess the ecological footprint of this compound and its derivatives.

Future directions in the study of 4,6-Dibromo-3-chloro-2-methylphenol may include exploring its role in medicinal chemistry beyond antimicrobial applications. Its structural framework could be modified to target other therapeutic areas such as oncology or central nervous system disorders. Collaborative efforts between synthetic chemists and biologists will be crucial in unlocking its full potential as a pharmacophore.

In conclusion,4,6-Dibromo-3-chloro-2-methylphenol (CAS No. 2167148-36-7) is a multifaceted compound with significant implications in pharmaceutical and agrochemical research. Its unique chemical properties make it a valuable intermediate for synthesizing bioactive molecules. As research continues to uncover new applications for this compound,4,6-Dibromo-3-chloro-2-methylphenol will likely remain at the forefront of innovation in organic chemistry and drug discovery.

• 111698-41-0(Benzonitrile, 3,5-dibromo-2-chloro-4-hydroxy-)
• 55289-31-1(4-Bromo-3-chloro-2-methylphenol)
• 1155264-58-6(1-Bromo-2-chloro-4-methoxy-3-methylbenzene)
• 1783711-62-5(2-Bromo-1-chloro-3-methoxy-4-methylbenzene)
• 1092460-50-8(4-Bromo-5-chloro-2-methylphenol)
• 1427373-68-9(3-Bromo-2-chloro-6-hydroxybenzaldehyde)
• 55289-30-0(3-Bromo-6-chloro-2-methoxytoluene)
• 55289-29-7(6-Bromo-3-chloro-2-methyl-phenol)
• 2090512-75-5(Phenol, 6-bromo-2-(bromomethyl)-3-chloro-)
• 187809-42-3(1,4-Benzenediol, 3-bromo-2-chloro-5-methyl-)